Assessing strength recovery after elbow fractures in elderly patients
Strength and Function After Non-operative Treatment of Displaced Olecranon Fractures in the Elderly: Implications of Standing UP From a Seat
This study looks at how well elderly patients recover strength and function after elbow fractures, comparing different treatment methods over a year.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50 (estimated) |
| Ages | 65 Years and up |
| Sex | All |
| Sponsor | Fraser Orthopaedic Research Society Research network |
| Locations | 1 site (New Westminster, British Columbia) |
| Trial ID | NCT05135949 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on elderly patients aged 65 and older who have sustained a Mayo type II olecranon fracture. Participants will receive either operative or non-operative treatment as determined by their surgeon. Their strength and functional ability will be evaluated at 6 weeks, 6 months, and 12 months post-treatment through assessments of range of motion, patient-reported outcomes, and strength tests. The goal is to understand the recovery process and outcomes associated with different treatment approaches.
Who should consider this trial
Good fit: Ideal candidates for this study are elderly individuals aged 65 and older with a Mayo type II olecranon fracture who are ambulatory.
Not a fit: Patients with additional injuries, cognitive impairments, or those unable to provide informed consent may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into optimal treatment strategies for improving strength and function in elderly patients with elbow fractures.
How similar studies have performed: While similar studies have explored recovery outcomes in elderly fracture patients, this specific approach focusing on strength after olecranon fractures is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. ≥65 years of age 2. Mayo type II olecranon fracture 3. Ambulatory (with or without the use of walking aides) Exclusion Criteria: 1. Additional injuries to the affected arm or contralateral arm 2. Associated nerve injury 3. Dementia or cognitive impairment that inhibits the collection of outcome measures 4. Likely problems, in the judgement of the investigator, with maintaining follow-up (i.e. patients with no fixed address, not mentally competent to give consent, intellectually challenged, patients without adequate support, etc.) 5. Injury or previous deficit to the contralateral arm 6. Currently enrolled in any other research study involving drugs or medical devices 7. Open fractures 8. Inability to provide informed consent
Where this trial is running
New Westminster, British Columbia
- Royal Columbian Hospital — New Westminster, British Columbia, Canada (Recruiting)
Study contacts
- Principal investigator: Farhad Moola, PhD — Orthopaedic Surgeon
- Study coordinator: Kyrsten Butterfield, BSc
- Email: kyrsten.butterfield@fraserhealth.ca
- Phone: 604-553-3247
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.